These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6454014)

  • 21. Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin.
    Blandino G; Dubini F; Russo G; Cocuzza G
    Clin Ther; 1980; 3(Spec Issue):103-11. PubMed ID: 6446383
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cefoperazone].
    Ueda Y
    Jpn J Antibiot; 1982 May; 35(5):1104-26. PubMed ID: 6215505
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical studies on cefoperazone in the pediatric field (author's transl)].
    Komaki K; Takita K; Mashiko J; Matsueda Y; Fujii R
    Jpn J Antibiot; 1980 Aug; 33(8):794-8. PubMed ID: 6451726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical study of cefacetrile in the treatment for orthopedic infections (author's transl)].
    Oto T; Yoshida M; Ueno H; Nishikawa M; Hayashi R
    Jpn J Antibiot; 1977 Jul; 30(7):484-7. PubMed ID: 909136
    [No Abstract]   [Full Text] [Related]  

  • 25. [Investigation on the antimicrobial activity of cefoperazone (author's transl)].
    Primavesi CA
    Immun Infekt; 1981 Jul; 9(4):150-3. PubMed ID: 6456219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of cefoperazone in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1980 Sep; 33(9):910-5. PubMed ID: 6452539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies on cefoperazone in gynecological and obstetrical field (author's transl)].
    Kanao M; Okada H; Iwasaki T; Ohshima K; Furuta N
    Jpn J Antibiot; 1981 Jan; 34(1):1-6. PubMed ID: 6454016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fundamental and clinical studies on cefoperazone in pediatrics, with special reference to renal toxicity].
    Tanaka A; Asami T; Nishihara T; Tomizawa S; Sakai K; Itoh S; Murai R; Kubota Y; Sasagawa F; Nishi K
    Jpn J Antibiot; 1985 Apr; 38(4):1037-48. PubMed ID: 4032719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and bacteriological aspects of pyoderma.
    Parikh DA; Fernandez RJ; Wagle UD
    J Postgrad Med; 1987 Oct; 33(4):189-92. PubMed ID: 3449622
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental and clinical studies of sulbactam/cefoperazone in pediatric field].
    Nakashima T; Ueda S; Hayakawa F; Miyachi Y; Hakamada S; Kuno K
    Jpn J Antibiot; 1984 Oct; 37(10):1846-58. PubMed ID: 6094864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies on cefoperazone in gynecological field (author's transl)].
    Yamaji K; Sugiyama Y; Seiga K; Minagawa M; Egawa J
    Jpn J Antibiot; 1980 Aug; 33(8):782-93. PubMed ID: 6451725
    [No Abstract]   [Full Text] [Related]  

  • 33. [Microbiological substantiation of the use of erycycline in the therapy of chronic pyoderma].
    Bukharovich AM
    Antibiotiki; 1982 Mar; 27(3):199-202. PubMed ID: 7092196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fundamental and clinical studies of cefpiramide in the field of obstetrics and gynecology].
    Ninomiya K; Ohbayashi F; Hasegawa Y
    Jpn J Antibiot; 1985 Aug; 38(8):2360-6. PubMed ID: 4079009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fundamental and clinical studies of cefamandole sodium in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1979 Sep; 32(9):912-29. PubMed ID: 387994
    [No Abstract]   [Full Text] [Related]  

  • 37. [General pharmacology of cefoperazone, a new cephalosporin antibiotic (author's transl)].
    Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N; Omori M; Muroda T; Nakajima S; Nakada Y; Tanada K; Senda N; Tanaka K; Makino H
    Jpn J Antibiot; 1980 Oct; 33(10):994-1018. PubMed ID: 6451724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].
    Imamura H; Kobayashi T; Murata K; Kohbata S; Watanabe I; Marui T; Watanabe K; Ninomiya K; Ueno K; Suzuki S
    Jpn J Antibiot; 1980 Nov; 33(11):1171-82. PubMed ID: 6454011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic activities of cefuzoname and the representative cephalosporins against clinically isolated methicillin resistant strains of Staphylococcus].
    Arai T
    Jpn J Antibiot; 1986 May; 39(5):1237-40. PubMed ID: 3463774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methicillin-resistant Staphylococcus aureus in community-acquired pyoderma.
    Nagaraju U; Bhat G; Kuruvila M; Pai GS; Jayalakshmi ; Babu RP
    Int J Dermatol; 2004 Jun; 43(6):412-4. PubMed ID: 15186220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.